These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Current therapies for cardiac allograft vasculopathy in children. Kindel SJ; Pahl E Congenit Heart Dis; 2012; 7(4):324-35. PubMed ID: 22613206 [TBL] [Abstract][Full Text] [Related]
9. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation. Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P; Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361 [TBL] [Abstract][Full Text] [Related]
10. Improved Detection of Cardiac Allograft Vasculopathy: A Multi-Institutional Analysis of Functional Parameters in Pediatric Heart Transplant Recipients. Kindel SJ; Law YM; Chin C; Burch M; Kirklin JK; Naftel DC; Pruitt E; Carboni MP; Arens A; Atz AM; Dreyer WJ; Mahle WT; Pahl E J Am Coll Cardiol; 2015 Aug; 66(5):547-57. PubMed ID: 26227194 [TBL] [Abstract][Full Text] [Related]
11. The pharmaceutical management of cardiac allograft vasculopathy after heart transplantation. Spitaleri G; Farrero Torres M; Sabatino M; Potena L Expert Opin Pharmacother; 2020 Aug; 21(11):1367-1376. PubMed ID: 32401066 [TBL] [Abstract][Full Text] [Related]
12. The clinical dilemma of cardiac allograft vasculopathy--an introduction to the clinical session. von Scheidt W Z Kardiol; 2000; 89 Suppl 9():IX/40-4. PubMed ID: 11151791 [TBL] [Abstract][Full Text] [Related]
14. Safety of optical coherence tomography in pediatric heart transplant patients. Ulrich SM; Lehner A; Birnbaum J; Heckel S; Haas NA; Hakami L; Schramm R; Dalla Pozza R; Fischer M; Kozlik-Feldmann R Int J Cardiol; 2017 Feb; 228():205-208. PubMed ID: 27866017 [TBL] [Abstract][Full Text] [Related]
15. The use of proliferation signal inhibitors in the prevention and treatment of allograft vasculopathy in heart transplantation. Delgado JF; Manito N; Segovia J; Almenar L; Arizón JM; Campreciós M; Crespo-Leiro MG; Díaz B; González-Vílchez F; Mirabet S; Palomo J; Roig E; de la Torre JM Transplant Rev (Orlando); 2009 Apr; 23(2):69-79. PubMed ID: 19298938 [TBL] [Abstract][Full Text] [Related]